Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023
Science 37 Holdings (Nasdaq: SNCE) will announce its fourth quarter 2022 financial results before the market opens on March 6, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Science 37 Holdings (Nasdaq: SNCE) will announce its fourth quarter 2022 financial results before the market opens on March 6, 2023. The management team will hold a conference call at 8:30 a.m. ET on the same day to discuss the results, accessible via phone or through an online link for immediate connection. Science 37 focuses on accelerating clinical research by providing universal trial access, employing a proprietary technology platform to enhance patient diversity and participation flexibility. The firm operates as a single Metasite™ to facilitate research participation, allowing remote access or traditional site involvement as needed.
Positive
- Upcoming fourth quarter 2022 financial results announcement on March 6, 2023.
- Management conference call scheduled for same day to discuss results.
- Focus on accelerating clinical research and universal trial access.
Negative
- None.
Details
News Market Reaction – SNCE
The recorded move for SNCE in the trading session of this news was -7.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial results prior to the market open on Monday, March 6, 2023.
The Science 37 management team will host a conference call to discuss these results on March 6, 2023, at 8:30 a.m. Eastern Time. The call can be accessed by dialing 1-877-269-7751 (toll-free domestic) or 1-201-389-0908 (international) using the conference ID 13736111 or by utilizing the Call me™ feature using this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Science 37 website. A replay of the webcast will be available for approximately 90 days.
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite™ Science 37 reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own home, at their local community provider, or at a traditional site when needed. The Science 37 Metasite is powered by a proprietary technology platform, in addition to in-house investigators, mobile nurses, and remote coordinators that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.
Contacts:
MEDIA INQUIRIES:
Grazia Mohren
Science 37
Email: pr@science37.com
INVESTOR RELATIONS:
Steve Halper
LifeSci Advisors
Email: shalper@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.